---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-055724"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:34:12.287187+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics shareholders approve reverse stock split of up to 1-for-20

## Summary
- Re-elected directors Chase, N. Dey, S. Dey, Wurth, Zeidman to 2026 term.
- Approved reverse stock split at 1-for-2 to 1-for-20 ratio; board may implement within one year.
- Approved additional reverse split (same ratio) contingent on first split being executed.
- Ratified Wolf & Company as independent auditor for FY 2025.
- Record date May 15, 2025; 616,134 shares voted from 1,494,182 outstanding.

## SEC filing metadata
- accession: 0001213900-25-055724
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390025055724/0001213900-25-055724-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390025055724/ea0246255-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-055724
- JSON: https://secwatch.observer/filing/0001213900-25-055724.json
- Plain text: https://secwatch.observer/filing/0001213900-25-055724.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
